Early DiAgnosis Real-Time Healthcare System for CANcer Trial

Recruiting now

Conditions studied: Polyps, Adenoma Colon, Colorectal Polyp, Colon Polyp, Polyps of Colon

In brief

The purpose of the study is to assess whether the AI characterisation system of the CADDIE device improves the endoscopists accuracy in the optical diagnosis of diminutive colorectal polyps in the bowel during colonoscopy. Participants will either have a colonoscopy with the assistance of the CADDIE device characterisation AI system ("intervention group") or have a colonoscopy in line with routine clinical practice i.e., without the CADDIE device characterisation AI system ("control group"). The randomisation method of this trial will allocate enrolled participants to the "intervention" group and to the "control" group by a technique similar to flipping a coin.

Key facts

Study ID

NCT05064124

Run by

University College, London

People needed

420

Starts

2024-07-18

Expected to finish

2025-05-01

Last updated by the study team

2024-12-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants scheduled to undergo a screening, surveillance or symptomatic colonoscopy with an endoscopist participating in the study phase of the trial.
• Male and female participants aged 18 years or older at the time of informed consent.
• Participants able to comprehend, sign and date the written informed consent document to participate in the study.

You may not qualify if…

• Emergency and/or inpatient colonoscopies
• Participants with inflammatory bowel disease (IBD)
• Participants with current Colorectal Cancer (CRC)
• Participants with a contraindication for biopsy or polypectomy. These include:
• Participants who have not withheld medications pre-disposing to bleeding at time of colonoscopy as per local site /national guidelines.
• Participants with a history of haemostasis disorders (haemostasis disorders will include but will not be limited to: participants with haemophilia or other congenitally acquired clotting factor deficiencies, participants with cirrhosis with coagulopathy, participants known to have thrombocytopenia (<80,000 platelet/ul) and individuals with Von Willebrand's disease or other known platelet malfunction disorders)
• Participant is enrolled in another research study with an investigational medicinal product (IMP) or non-IMP that pre-disposes them to bleeding

Where it is running

• University College London Hospitals NHS Foundation Trust — London, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.